Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation

Jo Thompson-Coon, Martin Hoyle, Colin Green, Zulian Liu, Karen Welch, Tiffany Moxham, Ken Stein

Research output: Book/Report › Commissioned report

Original language	English
Publisher	University of Exeter
Commissioning body	National Institute for Health and Care Excellence (NICE)
Number of pages	307
Publication status	Published - 2008
Externally published	Yes

Access to Document

@book{8af8501e63014df08d1286549e601308,

title = "Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation",

author = "Jo Thompson-Coon and Martin Hoyle and Colin Green and Zulian Liu and Karen Welch and Tiffany Moxham and Ken Stein",

year = "2008",

language = "English",

publisher = "University of Exeter",

}

TY - BOOK

T1 - Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma

T2 - a systematic review and economic evaluation

AU - Thompson-Coon, Jo

AU - Hoyle, Martin

AU - Green, Colin

AU - Liu, Zulian

AU - Welch, Karen

AU - Moxham, Tiffany

AU - Stein, Ken

PY - 2008

Y1 - 2008

UR - https://www.nice.org.uk/guidance/ta169

M3 - Commissioned report

BT - Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma

PB - University of Exeter

ER -